Literature DB >> 7936635

Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase.

J M Darbon1, A Devault, S Taviaux, D Fesquet, A M Martinez, S Galas, J C Cavadore, M Dorée, J M Blanchard.   

Abstract

Transitions of the cell cycle are controlled by cyclin-dependent protein kinases (cdks) whose phosphorylation on the Thr residue included in the conserved sequence YTHEVV dramatically increases the activity. A kinase responsible for this specific phosphorylation, called CAK for cdk-activating kinase, has been recently purified from starfish and Xenopus oocytes and shown to contain the MO15 gene product as a catalytic subunit. In the present paper, we have cloned the human homolog of Xenopus p40MO15 by probing a HeLa cell cDNA library with degenerate oligonucleotides deduced from Xenopus and starfish MO15 sequences. Human and Xenopus MO15 displayed a strong homology showing 86% identity with regard to amino acid sequences. Northern blot analysis of RNA extracts from a series of human tissues as well as from cultured rodent fibroblasts revealed a unique 1.4 kb MO15 mRNA. No variation in the amount of MO15 transcript or protein was found along the entire course of the fibroblast cell cycle. Fluorescence in situ hybridization on human lymphocyte metaphases showed two distinct chromosomal locations of human MO15 gene at 5q12-q13 and 2q22-q24. By using gene tagging and mammalian cell transfection, we demonstrate that the KRKR motif located at the carboxy terminal end of MO15 is required for nuclear targeting of the protein. Mutation of KRKR to NGER retains MO15 in the cytoplasmic compartment, whilst the wild-type protein is detected exclusively in the nucleus. Interestingly, we demonstrate that the nuclear targeting of MO15 is necessary to confer the protein its CAK activity. In contrast to the wild-type, the NLS-mutated MO15 expressed in Xenopus oocytes is unable to generate CAK as long as the nuclear envelope is not broken. The nuclear localization of both the MO15 gene product and CAK activity may imply that cdks activation primarily occurs in the cell nucleus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936635

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60.

Authors:  D Müller; K Thieke; A Bürgin; A Dickmanns; M Eilers
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

2.  The rice cyclin-dependent kinase-activating kinase R2 regulates S-phase progression.

Authors:  Tanja Fabian-Marwedel; Masaaki Umeda; Margret Sauter
Journal:  Plant Cell       Date:  2002-01       Impact factor: 11.277

3.  Cloning and characterization of p52, the fifth subunit of the core of the transcription/DNA repair factor TFIIH.

Authors:  J C Marinoni; R Roy; W Vermeulen; P Miniou; Y Lutz; G Weeda; T Seroz; D M Gomez; J H Hoeijmakers; J M Egly
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

Review 4.  Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".

Authors:  Laurence Bockstaele; Hugues Kooken; Frederick Libert; Sabine Paternot; Jacques E Dumont; Yvan de Launoit; Pierre P Roger; Katia Coulonval
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

6.  Interferon modulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells.

Authors:  H Yamada; K Ochi; S Nakada; S Takahara; T Nemoto; T Sekikawa; J Horiguchi-Yamada
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

7.  Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.

Authors:  Laurence Bockstaele; Xavier Bisteau; Sabine Paternot; Pierre P Roger
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

8.  Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.

Authors:  S A Ezhevsky; H Toyoshima; T Hunter; D W Scott
Journal:  Mol Biol Cell       Date:  1996-04       Impact factor: 4.138

9.  MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH.

Authors:  J P Adamczewski; M Rossignol; J P Tassan; E A Nigg; V Moncollin; J M Egly
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

10.  CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.

Authors:  Xavier Bisteau; Sabine Paternot; Bianca Colleoni; Karin Ecker; Katia Coulonval; Philippe De Groote; Wim Declercq; Ludger Hengst; Pierre P Roger
Journal:  PLoS Genet       Date:  2013-05-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.